About Accord Innovations
Accord Innovations is a company based in Bengaluru (India) founded in 2019 by Dilip Shankar. Accord Innovations has raised $70.54 thousand across 2 funding rounds from investors including C-CAMP. Accord Innovations operates in a competitive market with competitors including Sentien Biotechnologies, Lowell Therapeutics, Renapta, Kalera Medical and 3ive Labs, among others.
- Headquarter Bengaluru, India
- Founders Dilip Shankar
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Renify Technologies Private Limited
- Date of Incorporation 10 Sep, 2019
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$38 K (USD)-48.46as on Mar 31, 2023
-
Net Profit
-$23.62 K (USD)-1674.47as on Mar 31, 2023
-
EBITDA
-$19.23 K (USD)-920.74as on Mar 31, 2023
-
Total Equity Funding
$70.54 K (USD)
in 2 rounds
-
Latest Funding Round
$16.42 K (USD), Seed
Mar 23, 2022
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Accord Innovations
Accord Innovations has successfully raised a total of $70.54K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $16.42 thousand completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Accord Innovations
Accord Innovations has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include C-CAMP.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Bioscience research, innovation, and entrepreneurship facilitation in life sciences are conducted in India.
|
Locked | Locked | Locked |
Investor details for Accord Innovations
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Accord Innovations
Investment portfolio details for Accord Innovations
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Accord Innovations
Detailed financials for Accord Innovations
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Accord Innovations Comparisons
Peer comparison for Accord Innovations
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Accord Innovations
Accord Innovations operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sentien Biotechnologies, Lowell Therapeutics, Renapta, Kalera Medical and 3ive Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Stem cell-based devices for acute organ failure are developed.
|
|
| Locked | Locked | Locked |
Developer of anticoagulant for the treatment of acute kidney diseases
|
|
| Locked | Locked | Locked |
Offers a device for supporting end-stage renal impaired patients.
|
|
| Locked | Locked | Locked |
Develops innovative vacuum-assisted devices for kidney stone retrieval.
|
|
| Locked | Locked | Locked |
Develops innovative devices to restore kidney function.
|
Detailed competitors of Accord Innovations
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Accord Innovations
Complete news archive for Accord Innovations
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Accord Innovations
Accord Innovations was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Accord Innovations is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Dilip Shankar is the current CEO of Accord Innovations. They have also founded this company.
Accord Innovations is a funded company, having raised a total of $70.54K across 2 funding rounds to date.
Annual revenue of Accord Innovations is $38K as on Mar 31, 2023.
Accord Innovations was founded in 2019 in Bengaluru, India, focusing on medtech solutions. AI-based and sensor-based systems are utilized to monitor kidney function in real-time and detect renal dysfunction early. Operations center on device provision for acute kidney injury diagnosis, serving healthcare needs in the diagnostics sector. The domain accordinnovations.in is maintained for online presence. Leadership is provided by founder and CEO Dilip Shankar.
Accord Innovations's top competitors include Sentien Biotechnologies, Lowell Therapeutics and Renapta.
Accord Innovations has 1 investor. Key investors include C-CAMP.
The valuation of Accord Innovations is $455.9K as of Mar 2022.